CIK 0001178253 · Non-accelerated filer<br>Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 562181648
- Phone
- 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-04 | Angulo Gonzalez David Chief Medical Officer | Grant or award | +51,100 | 74,981 | ||
| 2022-02-04 | Angulo Gonzalez David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2021-06-16 | Tinmouth Brian Philippe Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-16 | Macdonald Guy Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-16 | HASTINGS DAVID C Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-16 | HANHAM ANN Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-16 | GILMAN STEVEN C Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-16 | ANIDO ARMANDO Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-05-10 | Coyne Christine Chief Commercial Officer | Grant or award | +15,000 | 15,000 | ||
| 2021-05-10 | Coyne Christine Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2021-01-29 | Taglietti Marco Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2021-01-29 | Sukenick Scott General Counsel | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-01-29 | Francois Eric Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2021-01-29 | Angulo Gonzalez David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2021-01-22 | PERCEPTIVE ADVISORS LLC 10% owner | Sale | −285,151 | $8.16 | $2.3M | 1,833,849 |
| 2021-01-22 | PERCEPTIVE ADVISORS LLC 10% owner | Sale | −33,849 | $8.95 | $303K | 1,800,000 |
| 2021-01-21 | PERCEPTIVE ADVISORS LLC 10% owner | Sale | −95,000 | $7.38 | $701K | 2,120,000 |
| 2021-01-20 | PERCEPTIVE ADVISORS LLC 10% owner | Sale | −185,000 | $7.43 | $1.4M | 2,215,000 |
| 2020-12-21 | Tinmouth Brian Philippe Director | Purchase | +8,000 | $6.25 | $50K | 8,000 |
| 2020-12-21 | Tinmouth Brian Philippe Director | Grant or award · Common Stock Warrant | +4,000 | 4,000 |
Page 6 of 9 · 165 trades